Mylan NV Ord Shs (MYL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | MYL | RDY | SUPN | ||
| Company | Mylan NV Ord Shs | Dr. Reddy's Laboratories Ltd ADR | Supernus Pharm | ||
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | ||
| Open | 15.64 | 12.43 | 47.74 | ||
| High | 16.15 | 12.51 | 48.18 | ||
| Low | 15.34 | 12.37 | 46.87 | ||
| Last | 15.86 | 12.42 | 47.15 | ||
| Change | +0.31 | +0.03 | -0.72 | ||
| Percent Change | +1.96% | +0.24% | -1.50% | ||
| Volume | 26,574,100 | 2,802,800 | 667,800 | ||
| 20-Day Average Volume | 8,612,350 | 2,904,830 | 1,012,950 | ||
| Previous | 15.55 | 12.39 | 47.87 | ||
| Industry | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 15.15 | 12.08 | 46.74 | ||
| 20-Day Raw Stochastic | 86.27% | 71.62% | 45.82% | ||
| 20-Day Relative Strength | 55.75 | 46.13 | 50.81 | ||
| Weighted Alpha | -23.10 | -15.30 | +5.30 | ||
| Today's Opinion | 40% Sell | 88% Sell | 56% Sell | ||
| Yesterday's Opinion | 64% Sell | 88% Sell | 56% Sell | ||
| Last Month's Opinion | 64% Sell | 56% Sell | 40% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +4.86% since 11/09/20 | +2.56% since 08/06/26 | +0.83% since 08/06/26 | ||
| Low | 15.10 on 11/10/20 | 11.58 on 08/10/26 | 46.26 on 08/12/26 | ||
| High | 16.15 on 11/16/20 | 12.58 on 08/11/26 | 48.60 on 08/11/26 | ||
| 1-Month | |||||
| %Chg | +0.92% since 10/16/20 | -3.87% since 07/13/26 | -0.42% since 07/13/26 | ||
| Low | 14.00 on 10/29/20 | 11.36 on 07/22/26 | 42.63 on 08/04/26 | ||
| High | 16.15 on 11/16/20 | 12.95 on 07/15/26 | 52.50 on 08/03/26 | ||
| 3-Month | |||||
| %Chg | -2.07% since 08/14/20 | -4.39% since 05/13/26 | -8.20% since 05/13/26 | ||
| Low | 14.00 on 10/29/20 | 11.36 on 07/22/26 | 42.45 on 06/16/26 | ||
| High | 17.03 on 08/19/20 | 15.67 on 06/26/26 | 52.50 on 08/03/26 | ||
| 6-Month | |||||
| %Chg | +4.58% since 05/15/20 | -12.16% since 02/13/26 | -7.26% since 02/13/26 | ||
| Low | 14.00 on 10/29/20 | 11.36 on 07/22/26 | 42.45 on 06/16/26 | ||
| High | 19.24 on 06/08/20 | 15.67 on 06/26/26 | 59.68 on 02/25/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 8,586,212 | 10,341,524 | 2,782,539 | ||
| Shares Outstanding, K | 541,546 | 834,667 | 58,127 | ||
| Annual Sales, $M | 11,500,500,000 | 3,580,000,000 | 718,950,000 | ||
| Annual Net Income, $M | 16,800,000 | 456,000,000 | -38,550,000 | ||
| Last Qtr Sales, $M | 2,972,100,000 | 853,000,000 | 219,060,000 | ||
| Last Qtr Income, $M | 185,700,000 | 47,000,000 | -58,370,000 | ||
| 60-Month Beta | 1.45 | 0.29 | 0.56 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.36 on 11/06/20 | 0.06 on 07/22/26 | 0.54 on 08/03/26 | ||
| Latest Earnings Date | 02/25/21 | 10/23/26 | 11/03/26 | ||
| Most Recent Dividend | 0.060 on 06/27/07 | 0.064 on 07/24/26 | N/A | ||
| Next Ex-Dividend Date | N/A | 07/24/26 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 3.29 | 26.49 | 22.87 | ||